CJC-1295 / IPAMORELIN nothing more. nothing less.
Ipamorelin / CJC-1295 (No DAC) is a dual-peptide research blend combining a selective GHS-R1a agonist with a GHRH analog. Studied in research involving synergistic GH release and endocrine pathway modeling.
Purity >99.93%Form Lyophilized PowderNo Endotoxins
Order within
—
Notify me when back in stock
For research use only — not for human consumption, therapeutic, or diagnostic use. By adding to cart you acknowledge these terms.
Blank. Credentials
Institutional-grade credentials you can verify
About This Compound
Deep technical insights for clinical research
Primary Research Applications
This compound is supplied strictly for in-vitro and preclinical research use only. Primary applications include the areas below.
Combines GHSR agonism with GHRH stimulation for enhanced and prolonged GH pulse generation through complementary mechanisms.
Stacks dual-pathway GH axis stimulation to maximize pulsatile release without desensitization of either receptor system.
Research Community Feedback
"Consistency is paramount in our cellular model testing. Blank's peptides have maintained the tightest purity specs of any RUO vendor we've audited."
Dr. Julian Kessler
Lead Investigator, Biomatrix Labs
"The availability of detailed MS and HPLC data on the product page saved us two days of redundant internal verification. Professional grade synthesis."
Anika S. Singh
Synthetics Quality Control
"Finally, a supplier that doesn't hide behind consumer marketing. Stark, clear, and high-purity. Exactly what a modern lab needs."
Prof. David Emmerich
Applied Peptide Research
Complete The Protocol
Pairs & Supplies
The compounds and tools researchers stack with CJC-1295 / IPAMORELIN.
Peer-Reviewed Literature
Related Studies
Ipamorelin, the First Selective Growth Hormone Secretagogue
European Journal of Endocrinology
Foundational paper establishing ipamorelin as a selective GHS-R1a agonist. Unlike GHRP-2 and GHRP-6, ipamorelin does not stimulate ACTH or cortisol, making it uniquely selective.
Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin in Human Volunteers
Pharmaceutical Research
Dose-escalation trial demonstrated ipamorelin produces a GH release episode peaking at 0.67 hours with terminal half-life of 2 hours across five dose levels in healthy male volunteers.
Ipamorelin Induces Longitudinal Bone Growth in Rats
Growth Hormone & IGF Research
Ipamorelin dose-dependently increased longitudinal bone growth rate from 42 to 52 µm/day with pronounced dose-dependent effects on body weight gain in adult female rats.
Prolonged Stimulation of Growth Hormone and Insulin-Like Growth Factor I Secretion by CJC-1295 in Healthy Adults
Journal of Clinical Endocrinology & Metabolism
Single injection of CJC-1295 produced dose-dependent GH increases of 2–10 fold sustained for 6+ days and IGF-I elevations of 1.5–3 fold for 9–11 days, with half-life of 5.8–8.1 days.
Pulsatile Secretion of Growth Hormone Persists During Continuous Stimulation by CJC-1295
Journal of Clinical Endocrinology & Metabolism
CJC-1295 increased trough and mean GH secretion and IGF-I production while preserving physiological GH pulsatility — distinguishing it from continuous GH replacement.
Activation of the GH/IGF-1 Axis by CJC-1295 Results in Serum Protein Profile Changes in Normal Adult Subjects
Growth Hormone & IGF Research
Proteomic analysis of sera from 11 healthy men demonstrated significant protein profile changes reflecting GH/IGF-1 axis activation one week after CJC-1295 injection.
From the Lab
Related Blog Posts
Mar 23, 2026
What Is Selank? The Anxiolytic Neuropeptide Redefining Stress and Cognitive Research
RESEARCH DISCLAIMERThis article reviews published scientific literature for educational purposes only. All compounds referenced are sold by Blank Peptides exclusively…
Mar 16, 2026
What Is Thymosin Alpha-1? The Immune-Modulating Peptide Redefining Infection and Inflammation Research
Thymosin Alpha-1 (Tα1) is a 28-amino acid thymic peptide driving renewed research interest in T-cell modulation, TLR signaling, infectious disease…
Mar 9, 2026
What Is AOD-9604? The Growth Hormone Fragment Reshaping Lipid Metabolism Research
RESEARCH DISCLAIMERThis article reviews published scientific literature for educational purposes only. All compounds referenced are sold by Blank Peptides exclusively…